Delivery Order SPE2DB22D3501-SPE2DB24FVF11
- Not listed
- This $5,342.09 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,564,786,012 capsules of the prescription drug Adderall XR 20mg. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of pharmaceutical products...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of 4,564,945,152 units of the prescription drug Adderall XR 20 mg capsules. The contract, valued at $1,061.73, was issued by the Medical Supply Chain division of the U.S. Department of Defense (DoD) and has a completion date of June 20, 2024. The contract is a Delivery Order under a Firm Fixed Price type with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,238.04 contract is for the delivery of 4,564,287,265 units of Adderall XR 20 mg capsules. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The delivery order, valued at $2,693.94, is for the supply of 4,564,220,248 units of Adderall XR 10 mg capsules. The contract is a firm fixed price, delivery order with an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,733.84 firm-fixed-price delivery order is for the supply of 4,565,024,917 units of the prescription medication Adderall XR 20 mg capsules. The contract has a completion date of June 28, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,901.80 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This order is for the supply of 4,563,828,106 Adderall XR 25 mg capsules and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of 4,564,096 Adderall XR 5 mg capsules. The $2,458.46 firm fixed price contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to provide pharmaceutical and medical supplies in support of military treatment programs and facilities. The contract has an...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation, is a delivery order valued at $2,766.80 for the supply of Adderall XR 20 mg capsules. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed price contract with a performance period through March 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,461.64 contract is for the supply of 4,563,731,620 units of Adderall XR 20 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $1,121.18 for the supply of Adderall XR 20 mg capsules. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 23, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVF11Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a $5,780.73 firm fixed price delivery order from the Defense Logistics Agency (DLA) for 4,564,222,724 units of Adderall XR 20 mg capsules. The award has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the award does not have a set-aside designation. In addition to this specific delivery order, Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. Amerisourcebergen Drug Corp also holds a separate indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division, valued at up to $750,000 through May 2024, to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 4/9/24 |